UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-24248 GENASYS INC. (Exact name of registrant as specified in its charter) Delaware 87-0361799 (State or other jurisdiction of ...

Spring 2023 Investor Presentation FORWARD-LOOKING STATEMENTS & DISCLOSURES Except for historical information contained herein, the matters parts, including semiconductor chips and integrated depreciation and amortization expense and stock discussed are forward-looking statements within the meaning -based compensation. We do not consider these circuits, resins, coating, and other equipment and of the “safe harbor” provisions of the Private Securities items to be indicative of our core operating components. N ...

Genasys Inc. (NASDAQ:GNSS) Q2 2023 Earnings Conference Call May 8, 2023 4:30 PM ET Company Participants Brian Alger – Senior Vice President-Investor Relations and Corporate Development Richard Danforth – Chief Executive Officer Dennis Klahn – Chief Financial Officer Conference Call Participants Brian Colley – Stephens Ed Woo – Ascendiant Capital Martin Yang – Oppenheimer Vivek Palani – Northland Capital Operator Good day, ladies and gentlemen. Welcome to the Genasys Incorporated Fiscal Second Quarter 2023 C ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-24248 GENASYS INC. (Exact name of registrant as specified in ...

Genasys Inc. (NASDAQ:GNSS) Q1 2023 Earnings Conference Call February 9, 2023 4:30 PM ET Corporate Participants Kim Rogers - Hayden IR Richard Danforth - Chief Executive Officer Dennis Klahn - Chief Financial Officer Conference Call Participants Brian Colley - Stephens Mike Latimore - Northland Capital Ed Woo - Ascendiant Capital Kris Tuttle - IPO Candy Martin Yang - Oppenheimer Operator Good day, ladies and gentlemen, and welcome to the Genasys Incorporated Fiscal First Quarter 2023 Conference Call. All lin ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark one) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number: 000-24248 GENASYS INC. (Exact name of registrant as specified in its charter) Delaware 87-0361799 (State or other jurisdiction ...